CVS Health Stock Price, Forecast & Analysis (NYSE:CVS)

CVS Health trades on the New York Stock Exchange (NYSE) under the ticker symbol "CVS."

CVS Health announced a quarterly dividend on Thursday, October 3rd. Investors of record on Thursday, October 24th will be given a dividend of $0.50 per share on Monday, November 4th. This represents a $2.00 dividend on an annualized basis and a yield of 2.69%. The ex-dividend date of this dividend is Wednesday, October 23rd. View CVS Health's Dividend History.

CVS Health Corp (NYSE:CVS) released its quarterly earnings results on Wednesday, November, 6th. The pharmacy operator reported $1.84 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.77 by $0.07. The pharmacy operator had revenue of $64.81 billion for the quarter, compared to analyst estimates of $62.99 billion. CVS Health had a net margin of 1.83% and a return on equity of 15.45%. The business's quarterly revenue was up 36.5% compared to the same quarter last year. During the same period in the prior year, the company posted $1.73 earnings per share. View CVS Health's Earnings History.

CVS Health is scheduled to release their next quarterly earnings announcement on Wednesday, February 19th 2020. View Earnings Estimates for CVS Health.

CVS Health issued an update on its FY19 earnings guidance on Wednesday, November, 6th. The company provided earnings per share (EPS) guidance of $6.97-7.05 for the period, compared to the Thomson Reuters consensus estimate of $6.98.

26 Wall Street analysts have issued 1-year target prices for CVS Health's shares. Their forecasts range from $61.00 to $91.00. On average, they expect CVS Health's stock price to reach $77.59 in the next twelve months. This suggests a possible upside of 4.4% from the stock's current price. View Analyst Price Targets for CVS Health.

26 Wall Street analysts have issued "buy," "hold," and "sell" ratings for CVS Health in the last year. There are currently 7 hold ratings, 18 buy ratings and 1 strong buy rating for the stock, resulting in a consensus recommendation of "Buy." View Analyst Ratings for CVS Health.

Media stories about CVS stock have trended positive on Sunday, according to InfoTrie Sentiment Analysis. InfoTrie identifies positive and negative press coverage by reviewing more than six thousand blog and news sources. The firm ranks coverage of public companies on a scale of -5 to 5, with scores closest to five being the most favorable. CVS Health earned a news impact score of 3.0 on InfoTrie's scale. They also assigned media stories about the pharmacy operator a news buzz of 0.0 out of 10, meaning that recent press coverage is extremely unlikely to have an impact on the company's share price in the near future. View News Stories for CVS Health.

Some companies that are related to CVS Health include Walgreens Boots Alliance (WBA), Covetrus (CVET), Rite Aid (RAD), Petmed Express (PETS), 111 (YI), Diplomat Pharmacy (DPLO), China Jo-Jo Drugstores (CJJD), HealthWarehouse.com (HEWA) and Dougherty's Pharmacy (MYDP).

Based on aggregate information from My MarketBeat watchlists, some companies that other CVS Health investors own include AT&T (T), Walt Disney (DIS), NVIDIA (NVDA), Cisco Systems (CSCO), Alibaba Group (BABA), Johnson & Johnson (JNJ), Verizon Communications (VZ), Home Depot (HD), Intel (INTC) and Bank of America (BAC).

CVS Health's stock is owned by many different of retail and institutional investors. Top institutional shareholders include Parnassus Investments CA (0.64%), Veritas Asset Management LLP (0.52%), Sumitomo Mitsui Trust Holdings Inc. (0.38%), California Public Employees Retirement System (0.24%), Coho Partners Ltd. (0.20%) and Rhumbline Advisers (0.18%). Company insiders that own CVS Health stock include C David Brown II, David M Denton, David W Dorman, Edward J Ludwig, Eva C Boratto, Helena Foulkes, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Kevin Hourican, Larry J Merlo, Lisa Bisaccia, Troyen A Brennan and Vost Collin. View Institutional Ownership Trends for CVS Health.

CVS stock was sold by a variety of institutional investors in the last quarter, including Veritas Asset Management LLP, Focused Investors LLC, Sumitomo Mitsui Trust Holdings Inc., Diamond Hill Capital Management Inc., Russell Investments Group Ltd., State of New Jersey Common Pension Fund D, Alta Capital Management LLC and Rothschild Investment Corp IL. Company insiders that have sold CVS Health company stock in the last year include David M Denton, Eva C Boratto, James David Clark, Jonathan C Roberts, Joshua Matthew Flum, Larry J Merlo and Troyen A Brennan. View Insider Buying and Selling for CVS Health.

CVS stock was bought by a variety of institutional investors in the last quarter, including Parnassus Investments CA, Artemis Investment Management LLP, Haverford Trust Co., California Public Employees Retirement System, Polaris Greystone Financial Group LLC, Atalanta Sosnoff Capital LLC, Assenagon Asset Management S.A. and Poplar Forest Capital LLC. Company insiders that have bought CVS Health stock in the last two years include C David Brown II, David W Dorman and Edward J Ludwig. View Insider Buying and Selling for CVS Health.

Shares of CVS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of CVS stock can currently be purchased for approximately $74.29.

CVS Health has a market capitalization of $96.65 billion and generates $194.58 billion in revenue each year. The pharmacy operator earns $-594,000,000.00 in net income (profit) each year or $7.08 on an earnings per share basis. CVS Health employs 295,000 workers across the globe.View Additional Information About CVS Health.

The official website for CVS Health is http://www.cvshealth.com/.

CVS Health's mailing address is ONE CVS DR., WOONSOCKET RI, 02895. The pharmacy operator can be reached via phone at 401-765-1500 or via email at [email protected]